Resultados de búsqueda - (sense OR (consiste OR (compcppcppcppcppcppcpppppenso OR compcppcppcppcppcppcpppppenso)))

  1. 1001
  2. 1002
  3. 1003
  4. 1004
  5. 1005
  6. 1006
  7. 1007
  8. 1008
  9. 1009
  10. 1010
  11. 1011
  12. 1012
  13. 1013
  14. 1014
  15. 1015
  16. 1016
  17. 1017
  18. 1018
  19. 1019
  20. 1020

    The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type... por Yale, Jean François, Pettus, Jeremy Hodson, Brito Sanfiel, Miguel, Lavalle González, Fernando Javier, Merino Trigo, Ana, Stella, Peter, Chevalier, Soazig, Buzzetti, Raffaella

    Publicado 2018
    “…The cumulative mean number of confirmed (≤3.9 mmol/L [≤70 mg/dL]) or severe hypoglycaemic events, and the risk and annualised rate of such events, were consistently lower for Gla-300 than Gla-100 during the night (between 00:00 and 05:59 h) or at any time of day (24 h period), irrespective of DPPIVi use. …”
    Enlace del recurso
    Artículo

Herramientas de búsqueda: